Skip to content
10-K

Annual Report

VAXXINITY, INC.

0001562762-24-000071

← back to feed
Filed
Mar 27, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2023 · Dec 31, 2023 126.51M sh
Shares Diluted FY 2023 · Dec 31, 2022 125.94M sh
Capex FY 2023 · Dec 31, 2023 $803K
Capex FY 2023 · Dec 31, 2022 $1.87M
Operating Cash Flow FY 2023 · Dec 31, 2023 −$57.24M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$55.93M
Short Term Investments FY 2023 · Dec 31, 2023 $25.46M
Short Term Investments FY 2023 · Dec 31, 2022 $53.35M
Cash And Equivalents FY 2023 · Dec 31, 2023 $4.93M
Cash And Equivalents FY 2023 · Dec 31, 2022 $33.48M
Stockholders Equity FY 2023 · Dec 31, 2023 $13.41M
Stockholders Equity FY 2023 · Dec 31, 2022 $62.18M
Stockholders Equity FY 2023 · Dec 31, 2021 $128.62M
Current Liabilities FY 2023 · Dec 31, 2023 $17.61M
Current Liabilities FY 2023 · Dec 31, 2022 $30.94M
Total Liabilities FY 2023 · Dec 31, 2023 $30.9M
Total Liabilities FY 2023 · Dec 31, 2022 $44.22M
Current Assets FY 2023 · Dec 31, 2023 $33.23M
Current Assets FY 2023 · Dec 31, 2022 $93.89M
Total Assets FY 2023 · Dec 31, 2023 $44.31M
Total Assets FY 2023 · Dec 31, 2022 $106.4M
Eps Diluted FY 2023 · Dec 31, 2023 −$0.45
Eps Diluted FY 2023 · Dec 31, 2022 −$0.60
Eps Basic FY 2023 · Dec 31, 2023 −$0.45
Eps Basic FY 2023 · Dec 31, 2022 −$0.60
Sga Expense FY 2023 · Dec 31, 2023 $22.39M
Sga Expense FY 2023 · Dec 31, 2022 $28.35M
Rd Expense FY 2023 · Dec 31, 2023 $35.9M
Rd Expense FY 2023 · Dec 31, 2022 $47.63M
Net Income FY 2023 · Dec 31, 2023 −$56.93M
Net Income FY 2023 · Dec 31, 2022 −$75.22M
Operating Income FY 2023 · Dec 31, 2023 −$58.29M
Operating Income FY 2023 · Dec 31, 2022 −$75.98M